ArticleJournal of clinical medicine2023

Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease.

Edoardo Benedetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.